Quality Assured: Jeevan Scientific Hyderabad Unit Passes USFDA Audit with Zero Flaws

HYDERABAD — Clinical research and contract research organization (CRO) Jeevan Scientific Technology Limited announced a major regulatory milestone on Friday, July 24, 2026, confirming that the United States Food and Drug Administration (USFDA) successfully completed its inspection of the company's facility in Hyderabad. According to official corporate disclosures, the regulatory review concluded with no observations or Form 483 citations issued. This development is vital today as international pharmaceutical developers increasingly prioritize compliance transparency, data integrity, and uncompromised quality standards in clinical trials.

Regulatory Compliance and Facility Audit Overview

The evaluation conducted by the USFDA involved rigorous scrutiny of clinical pharmacology, bioanalytical operations, and quality management systems at the Hyderabad premises. Regulatory authorities assess adherence to international good clinical practice (GCP) and good laboratory practice (GLP) benchmarks to ensure absolute safety and data reliability for global drug submissions.

According to filings submitted to stock exchange desks, the inspection concluded cleanly, marking another milestone in the company's compliance history. Maintaining an inspection record clear of critical findings underscores the operational precision upheld by domestic contract research organizations supporting global pharmaceutical pipelines.

Background on Contract Research and Quality Standards

The clinical research sector relies heavily on stringent regulatory compliance to secure cross-border drug approvals and maintain partnerships with multi-national pharmaceutical enterprises.

• Global Credibility: Zero-observation regulatory closures reinforce institutional confidence among international clients seeking reliable bioequivalence and clinical trial execution.

• Operational Rigor: Stringent adherence to documentation protocols ensures seamless integration into global medicine development frameworks.

• Market Position: Clean audit outcomes allow specialized CROs to expand service offerings without regulatory bottlenecks or remediation delays.

Official Sources and Regulatory Disclosures

Compliance confirmations and statutory notices are managed through formal corporate communications.

"According to official announcements and regulatory filings submitted by Jeevan Scientific Technology Limited, the USFDA inspection of the Hyderabad clinical facility was closed successfully with zero observations."

All compliance filings and investor updates are available via the National Stock Exchange of India (NSE) and the BSE Limited.

Why It Matters

For pharmaceutical sponsors, clinical researchers, and market investors, a clean USFDA inspection eliminates regulatory overhang and validates the operational integrity of outsourced research facilities. Ensuring error-free compliance safeguards ongoing multi-national clinical programs and strengthens India's standing as a trusted hub for advanced medical research and drug development.

Key Facts at a Glance

• Reporting Entity: Jeevan Scientific Technology Limited.

• Facility Location: Hyderabad, Telangana.

• Regulatory Body: United States Food and Drug Administration (USFDA).

• Audit Outcome: Inspection closed successfully with zero observations or Form 483 citations.

Frequently Asked Questions (FAQ)

What was the outcome of the USFDA inspection at Jeevan Scientific Technology?

The USFDA inspection concluded successfully with zero observations or citations issued against the facility.

Which facility was subjected to the USFDA review?

The evaluation covered the company's specialized clinical and bioanalytical research infrastructure located in Hyderabad.

Why are zero-observation USFDA audits important for a CRO?

Clean audit results validate data integrity, enhance global client trust, and ensure uninterrupted execution of international clinical and bioequivalence studies.

Where can official regulatory updates for Jeevan Scientific Technology be verified?

Official disclosures and compliance reports can be accessed through the National Stock Exchange of India (NSE) and the BSE Limited.

Source: National Stock Exchange of India (NSE), BSE Limited, and Jeevan Scientific Technology Corporate Disclosures.